GZMB and breast carcinoma: Low expression of the Granzyme B gene (GZMB) in combination with ING4-deficiencies was significantly associated with poor patient survival in the basal subtype of breast cancer, supportive of the clinical significance of granzyme-B-positive immune cell depletion in ING4-deficient tumors.